Trials / Approved For Marketing
Approved For MarketingNCT02464943
Zenith® Dissection Endovascular System in the Treatment of Patients With Aortic Dissections
Zenith® Dissection Endovascular System in the Treatment of Patients With Acute, Complicated Type B Aortic Dissections
- Status
- Approved For Marketing
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Cook Research Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Zenith® Dissection extended study is to collect confirmatory safety and effectiveness data on the Zenith® Dissection Endovascular System in the treatment of acute, complicate Type B aortic dissection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endovascular Treatment (Zenith) | Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta. |
Timeline
- First posted
- 2015-06-08
- Last updated
- 2020-01-18
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02464943. Inclusion in this directory is not an endorsement.